This study should prompt further work aiming at establishing the role of CDK4 in contributing to tumor/cancer genetic risk predisposition, as well as its role as a potentially effective therapeutic target gene for obesity-associated tumor/cancer management. Here, CDK4 is linked to obesity due to melanocortin 4 receptor deficiency.